Verastem, Inc. (VSTM) News

Latest headlines that mention VSTM, newest first · each headline opens the original publisher

VSTM quote

Last price: $8.62
Day change: -0.35%
Next earnings: 2026-11-03

Quote & chart Expected move Insider trading IV rank history

VSTM headlines

last 30 days

Seeking Alpha News 5d ago

Verastem: A Real Pancreatic Cancer Drug, Arriving Second

General T2VSTM

Seeking Alpha News 5d ago

Verastem, Inc. (VSTM) Discusses New Clinical Data for VS-7375 KRAS G12D Inhibitor in Pancreatic, Lung, and Colorectal Cancers Transcript

General T2VSTM

Seeking Alpha News 5d ago

Verastem, Inc. (VSTM) Discusses New Clinical Data for VS-7375 KRAS G12D Inhibitor in Pancreatic, Lung, and Colorectal Cancers - Slideshow

General T2VSTM

Seeking Alpha 6d ago

Verastem Oncology jumps after announcing CEO transition, pricing $250M securities offering

General T2VSTM

Seeking Alpha News 14d ago

Verastem: A Two-For-One Clinical Readout In October And A Commercial Launch

General T2VSTM

Investing.com 14d ago

Verastem stock maintained at Buy by BTIG ahead of data readout

General T3VSTM

Investing.com 26d ago

Verastem CFO Daniel Calkins sells $423 in company stock

General T3VSTM

VSTM news alerts

Get an alert by email or push when a new headline mentions VSTM.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.